Effectiveness of group acceptance and commitment therapy in treating depression for acute stroke patients

Brain Behav. 2023 Dec;13(12):e3260. doi: 10.1002/brb3.3260. Epub 2023 Nov 8.

Abstract

Objectives: To date, the effectiveness of acceptance and commitment therapy (ACT) for acute stroke patients has not been well recognized. The study aimed to discover the effectiveness of group-based ACT in treating depression for acute stroke patients.

Methods: We conducted a randomized controlled trial with 140 acute stroke patients with depression. The ACT intervention comprised seven sessions, of 45-60 min over 4 weeks. Data were collected pre- and post-intervention and at 3-month follow-up, assessing depression, health-related quality of life (HRQoL), psychological flexibility, cognitive fusion, sleep quality, and confidence.

Results: Overall, 99.3% of the included patients were assessed as having mild depression. The ACT intervention significantly reduced depression in acute stroke patients in comparison with the control group post-intervention and at 3 months (partial η 2 = . 306 $\eta^{2}=.306$ ). Additionally ACT significantly improved HRQoL-mental component summary, sleep quality, psychological flexibility, cognitive fusion, and confidence compared with control group.

Conclusions: ACT is effective in treating acute stroke patients with depression, and the efficacy was maintained at 3-month follow-up.

Trial registration: ClinicalTrials.gov NCT05727358.

Keywords: acceptance and commitment therapy; acute stroke; depression; effectiveness; nurse.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acceptance and Commitment Therapy*
  • Depression / therapy
  • Humans
  • Quality of Life
  • Stroke* / complications
  • Stroke* / psychology
  • Stroke* / therapy
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT05727358